Immundiagnostik

Immundiagnostik

Bensheim, Germany· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $3.7M

Overview

Immundiagnostik AG is a long-established, privately-held German diagnostics company focused on niche immunological assays and reagents. It operates a diversified business model encompassing in-house development and manufacturing of ELISA/EIA kits, LC-MS/MS applications, antibodies, and contract analytical services. The company targets specific diagnostic needs in areas like celiac disease and histamine intolerance, leveraging its expertise to serve clinical labs and research institutions. Its strategy is built on certified quality, continuous innovation, and direct customer relationships.

Autoimmune DiseasesGastrointestinal DisordersFood Intolerances

Technology Platform

Integrated immunodiagnostics platform specializing in ELISA/EIA, LC-MS/MS/HPLC applications, PCR, photometric tests, and proprietary antibody (polyclonal/monoclonal) development.

Funding History

2
Total raised:$3.7M
Grant$1.2M
Seed$2.5M

Opportunities

The stringent EU IVDR regulations create a barrier to entry that can benefit established, quality-focused players like Immundiagnostik.
Growing consumer and clinical awareness of food-related disorders (e.g., celiac disease, histamine intolerance) drives demand for specialized diagnostic tests.

Risk Factors

Intense competition in the IVD market from both large conglomerates and agile niche players.
The complexity and cost of maintaining compliance with evolving global regulations, especially the EU IVDR, could strain resources.
Reliance on niche markets may limit total addressable market size and growth potential.

Competitive Landscape

Immundiagnostik competes in specialized segments against other focused diagnostic companies (e.g., Euroimmun, Thermo Fisher's specialty diagnostics units) and the research reagent divisions of larger biotech firms. Its competitive advantage lies in its deep niche expertise, integrated antibody and assay development, and reputation for quality in its specific diagnostic areas.